Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
49 Results
Clear Filters
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
Taking on Type 1 Diabetes: Researchers and Patient Advocates Unite in the Quest for a Cure
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
Using Stem Cells and Gene Editing to Fight Neonatal Diabetes
The Context: Neonatal diabetes affects between 1 and 5 percent of all diabetes patients. It is caused by a single genetic mutation that prevents pancreatic beta...
Translational Research Takes Center Stage at NYSCF Conference
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
NYSCF and Lyfebulb Announce Collaboration on Chronic Disease Research and Education
Lyfebulb, a patient-empowerment platform that connects chronic disease patients, industry, and investors to empower patients and support user-driven innovation, and The New York Stem Cell Foundation...
Four NYSCF Innovators Featured In Nature Article on Embryonic Stem Cell Research
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Cutting-Edge Research Highlights The NYSCF Conference
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF Innovator Makes Step Towards Therapies for Metabolic Diseases
NYSCF – Robertson Investigator Alumna Dr. Shuibing Chen published her latest work in Cell Stem Cell creating stem cell models of type 2 diabetes in a...
New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
The Wall Street Journal Profiles NYSCF CEO and Co-Founder Susan L. Solomon
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...
NYSCF 10th Annual Conference: Two Nobel Laureates to Chair and Participate on Panels
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
NYSCF Announces 2014 Class of NYSCF – Druckenmiller Fellows
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
SCNT – Susan Solomon and Dr. Dieter Egli Discuss NYSCF’s Latest Breakthrough
Dr. Dieter Egli, NYSCF Senior Research Fellow, discusses his latest somatic cell nuclear transfer (SCNT) research with NYSCF CEO Susan L. Solomon.
First Disease-Specific Stem Cell Line by SCNT
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
Stem Cell Search
The NYSCF Research Institute makes stem cell lines available through its stem cell repository. To search for specific cell lines, a specialized stem cell search interface...
NYSCF Scientists Find Compound To Preserve Beta Cell Function in Diabetes Model
NYSCF scientists published a paper today in the journal Diabetes on a breakthrough in diabetes research that could lead to new therapeutic approaches for patients with a...
NYSCF Research Institute and Columbia University Researchers Use Patient-Specific Stem Cells to Identify Treatment for Diabetes
In a first for the field, NYSCF scientists with Columbia University’s Naomi Berrie Diabetes Center researchers have generated patient-specific beta cells, or insulin-producing cells, that accurately...
NYSCF Research Institute and Columbia University Researchers Use Patient-Specific Stem Cells to Identify Treatment for Diabetes
In a first for the field, NYSCF scientists with Columbia University's Naomi Berrie Diabetes Center researchers have generated patient-specific beta cells, or insulin-producing cells, that accurately...
Scientists Model Rare Neurodegenerative Disease in a Dish
Scientists from UCLA have succeeded in modelling ataxia telangiectasia (A-T), a rare genetic disorder, in a dish. This neurodegenerative disease affects 1 in 100,000 worldwide, with...
Scientists Identify New Hormone that Boosts Insulin-Producing Cells
Led by Douglas Melton, PhD, Harvard Stem Cell Institute Principal Faculty member and NYSCF Medical Advisory Board Executive Committee member, a new Cell study identifies a hormone in...
Isolated Pancreas Stem Cells Can Become Beta Cells
Walter and Eliza Hall Institute researchers led by Leonard Harrison, DSc, identified and isolated stem cells from the pancreas, and they thenderived insulin-producing beta cells. While...
WSJ: “Stem Cell Heroes Show Off at Fair”
From the Wall Street Journal, "The New York Stem Cell Foundation gala isn't just a party: It is also a science fair illustrating state-of-the-art stem cell research....
In Cell, Chutima Talchai Demonstrates Insulin-Producing Cells De-differentiate in Type 2 Diabetes
Counter to the prevailing theory that beta cells die-off in Type 2 diabetes patients, NYSCF – Druckenmiller Fellow and postdoctoral research scientist at Columbia University Medical...